Russell Investments Group’s Fortress Biotech FBIO Stock Holding History

Russell Investments Group’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,080	Closed	-$3K	–	3727
2024 Q3	$3K	Hold	2,080	–	–	﹤0.01%	3314
2024 Q2	$3.56K	Hold	2,080	–	–	﹤0.01%	3280
2024 Q1	$4.16K	Hold	2,080	–	–	﹤0.01%	2969
2023 Q4	$6.26K	Hold	2,080	–	–	﹤0.01%	2881
2023 Q3	$9.06K	Hold	2,080	–	–	﹤0.01%	3035
2023 Q2	$17.2K	Hold	2,080	–	–	﹤0.01%	2865
2023 Q1	$25.6K	Hold	2,080	–	–	﹤0.01%	2786
2022 Q4	$20.4K	Hold	2,080	–	–	﹤0.01%	2798
2022 Q3	$26K	Hold	2,080	–	–	﹤0.01%	2791
2022 Q2	$26K	Hold	2,080	–	–	﹤0.01%	2776
2022 Q1	$42K	Hold	2,080	–	–	﹤0.01%	2637
2021 Q4	$78K	Sell	2,080 -401	-16%	-$17.9K	﹤0.01%	2864
2021 Q3	$119K	Sell	2,481 -10,820	-81%	-$528K	﹤0.01%	2866
2021 Q2	$711K	Buy	13,301 +3,695	+38%	+$223K	﹤0.01%	2460
2021 Q1	$507K	Sell	9,606 -645	-6%	-$36.4K	﹤0.01%	2520
2020 Q4	$488K	Sell	10,251 -2,931	-22%	-$127K	﹤0.01%	2440
2020 Q3	$796K	Buy	+13,182	New	+$671K	﹤0.01%	2165

Other funds holding FBIO

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Russell Investments Group's FBIO Position: Q4 2024 in Review

Russell Investments Group sold out of Fortress Biotech (FBIO) in Q4 2024, closing a stake of 2,080 shares — an estimated $3K sold.

Russell Investments Group first reported a position in FBIO in Q3 2020 and held it in 17 quarters. The position peaked at $796K in Q3 2020. 53 funds tracked by Wall St. Rank hold FBIO as of Q4 2024.

Russell Investments Group reported no remaining Fortress Biotech position as of Q4 2024 after selling out during the quarter.
Russell Investments Group sold 2,080 Fortress Biotech shares in Q4 2024, an estimated $3K.
Russell Investments Group first reported a position in Fortress Biotech in Q3 2020 and held it in 17 quarters.
Russell Investments Group's Fortress Biotech position peaked at $796K in Q3 2020.
53 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.